Table 1. Clinical characteristics and laboratory results of patient with COVID-19 pneumonia (n=66).
| Characteristic | Number (%) |
| Male | 43 (65%) |
| Female | 23 (35%) |
| > 50 years old | 21 (32%) |
| ≤ 50 years old | 45 (68%) |
| Exposure to COVID-19 pneumonia patients | 4 (6%) |
| Lived in or visited Wuhan during the epidemic | 21 (32%) |
| Unknown exposure | 41 (62%) |
| Symptoms | |
| Fever | 60 (91%) |
| Cough | 37 (56%) |
| Sore throat | 17 (26%) |
| Sputum | 16 (24%) |
| Fatigue | 15 (23%) |
| Dyspnoea | 14 (21%) |
| Dizziness | 9 (14%) |
| Myalgia | 7 (11%) |
| Headache | 3 (5%) |
| Diarrhoea | 3 (5%) |
| Nausea | 3 (5%) |
| Rhinorrhea | 2 (3%) |
| C-reactive protein (mg/L; normal range 0-10) | |
| Increased | 38 (58%) |
| Decreased | 0 |
| Normal | 28 (42%) |
| Leucocytes (× 109, normal range 3.5-9.5) | |
| Increased | 1 (2%) |
| Decreased | 14 (21%) |
| Normal | 51 (77%) |
| Lymphocyte (× 109, normal range 1.1-3.2) | |
| Increased | 0 |
| Decreased | 29 (44%) |
| Normal | 37 (56%) |
| Comorbid conditions | |
| Any | 12 (18%) |
| Hepatitis or liver cirrhosis | 8 (12%) |
| Hypertension | 4 (6%) |
| Diabetes | 2 (3%) |
| Chronic pulmonary disease | 1 (2%) |
| Cardiovascular disease | 1 (2%) |